Lung inflammatory pattern and antibiotic treatment in pneumonia

Autores de IIS La Fe

• Maria Jose Lorenzo Dus

  Autor

• Inés Moret Tatay

  Autor

• Benjamin Sarria Chust

  Autor

• Enrique Cases Viedma

  Autor

• Julio Cortijo Gimeno

  Autor

• Raúl Méndez Ocaña

  Autor

• Rosario Menéndez Villanueva

  Autor

Participantes ajenos a IIS La Fe

• Molina J
• Gimeno A

Grupos

• Enfermedad Inflamatoria Intestinal

• Infecciones Respiratorias

Abstract

Background: In community-acquired pneumonia host inflammatory response against the causative microorganism is necessary for infection resolution. However an excessive response can have deleterious effects. In addition to antimicrobial effects, macrolide antibiotics are known to possess immunomodulatory properties. We aimed to evaluate inflammatory cytokine profiles - both locally (bronchoalveolar lavage) and systemically (blood) - in community-acquired pneumonia admitted patients after at least 72 hours of antibiotic treatment (with and without macrolide containing regimens) and requiring bronchoscopic examination for inadequate response due to infection progression and/or lack of clinical stability. Methods: A prospective study was performed on 52 admitted patients who developed an inadequate response after 72 hours of antibiotic treatment -non-responders community-acquired pneumonia - (blood and bronchoalveolar lavage), and two control groups: 1) community-acquired pneumonia control (blood) and 2) non-infection control (blood and bronchoalveolar lavage). Cytokine profiles (interleukin (IL)-6, IL-8, IL-10), tumour necrosis factor a and clinical outcomes were assessed. Results: Non-responders patients treated with macrolide containing regimens showed significantly lower levels of IL-6 and TNF-alpha in bronchoalveolar lavage fluid and lower IL-8 and IL-10 in blood than those patients treated with non-macrolide regimens. Clinical outcomes showed that patients treated with macrolide regimens required fewer days to reach clinical stability (p < 0.01) and shorter hospitalization periods (p < 0.01). Conclusions: After 72 hours of antibiotic effect, patients who received macrolide containing regimens exhibited lower inflammatory cytokine levels in pulmonary and systemic compartments along with faster stabilization of infectious parameters.

Keywords

• Community acquired pneumonia; Macrolides; Lung inflammation